Skip to main content
Premium Trial:

Request an Annual Quote

Cellectis, Two Blades Ink TALEN Technology Cross-licensing Deal

NEW YORK (GenomeWeb) – Ag-bio organizations Cellectis Plant Sciences and the Two Blades Foundation announced that they have signed a cross-licensing agreement for their respective TAL effector nuclease gene-editing technologies.

Under the deal, Two Blades has received a license to Cellectis' TALEN technology for non-profit uses, including its efforts to support subsistence farming, as well as certain commercial applications related to its ongoing disease-resistance programs.

Cellectis has received a license to Two Blades' TAL effector code technology related to nucleases for commercial uses in certain undisclosed crop plants. Cellectis has also been granted an option to expand its license to additional crops.

Financial terms of the arrangement were not disclosed.